CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 15 enrolled
Drug / intervention
Sirolimus-coated Bx VELOCITY Stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00233818
NCT00233818Phase 2Completed
CompareCT.gov

An Evaluation of Sirolimus-Coated Modified BX VELOCITY Balloon-Expandable Stents for the Treatment of Patients With de Novo Native Coronary Artery Lesions

Cordis US Corp.·interventional·Posted Oct 6, 2005·Updated Oct 12, 2007

In Brief

A Phase 2 clinical trial evaluating Sirolimus-coated Bx VELOCITY Stent for Coronary Artery Disease. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The objective of this study is to assess the performance and safety of a formulation of the antiproliferative agent, sirolimus coated on modified Bx VELOCITY Balloon-Expandable Stent mounted on the Raptor Over The Wire (OTW) Stent Delivery System (SDS) in patients with de novo coronary artery lesions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesNetherlands
Collaborators--

Timeline

Phase 2CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 6, 2005
Enrollment StartFeb 1, 2000
Study CompletionJun 1, 2005
TodayJul 2, 2026
Posted 20.7 years ago

Interventions

Sirolimus-coated Bx VELOCITY Stentdevice